Phase II clinical trial of bevacizumab plus ixabepilone in renal cell carcinoma.
Mauricio Emmanuel Burotto Pichun
No relevant relationships to disclose
Nicolas Acquavella
No relevant relationships to disclose
Maureen Edgerly
No relevant relationships to disclose
Susan Elaine Bates
No relevant relationships to disclose
Sanjeeve Balasubramaniam
No relevant relationships to disclose
Antonio Tito Fojo
No relevant relationships to disclose